期刊文献+

血清CA125、CEA及TAM联合检测在妇科肿瘤的临床诊断中的应用价值 被引量:7

The Application Value of Serum CA125,CEA and TAM Detection in the Clinical Diagnosis of Gynecological Tumors
下载PDF
导出
摘要 目的探讨血清糖类抗原125(CA125)、癌胚抗原(CEA)及肽结合羟脯氨酸(TAM)联合检测在妇科肿瘤的临床诊断中的应用价值。方法选取妇科肿瘤患者200例,以病理学诊断为对照,依据良恶性分为恶性组(n=50)和良性组(n=150)。采用电化学发光法检测血清CA125、CEA水平,采用化学比色法检测血清TAM水平,采用ROC曲线分析上述因子鉴别良恶性肿瘤的诊断效能,统计分析所有患者血清CA125、CEA、TAM水平。结果恶性组患者血清CA125、CEA及TAM水平明显高于良性组,差异有统计学意义(P<0.05)。ROC曲线分析结果显示,在鉴别良恶性肿瘤的敏感度、特异度、准确度方面,CA125以35 U/ml为临界值时,分别为81.00%、81.33%、82.00%;CEA以5.2 ng/ml为临界值时,分别为82.00%、83.33%、83.00%;TAM以95 U/ml为临界值时,分别为76.00%、80.00%、78.00%;三者联合检测时,分别为98.00%、94.00%、95.00%。三者联合检测的诊断价值明显高于三者单独检测,差异有统计学意义(P<0.05)。结论血清CA125、CEA及TAM水平与妇科肿瘤恶性病变有关,三者联合检测可有效提高鉴别妇科肿瘤良恶性病变的诊断效能,值得临床进一步推广。 Objective To discuss the application value of serum carbohydrate antigen 125( CA125),carcinoembryonic antigen( CEA) and tumor related substances( TAM) detection in the clinical diagnosis of gynecological tumors. Methods 200 patients with gynecological tumors were selected. In pathological diagnosis for comparison,according to the benign and malignant,all patients were divided into malignant group( n = 50) and benign group( n = 150),electrochemical luminescence method was used to detect the serum CA125,CEA levels,chemical colorimetry was used to detect serum level of TAM,ROC curve analysis was used to identify the above factor in the diagnostic performance of benign and malignant tumor,statistical analyzed all patients of serum CA125,CEA,TAM. Results The levels of serum CA125,CEA and TAM of malignant group patients were significantly higher than those of benign group,the difference was statistically significant( P 〈 0. 05); ROC curve analysis showed that,in differentiating benign and malignant tumors of sensitivity,accuracy,specific degree,CA125 in 35 u/ml of the critical value,were respectively 81. 00%,81. 33% and 81. 00%,the CEA to the critical value for 5. 2 ng/ml,were respectively 82. 00%,83. 33% and83. 00%,TAM to 95 u/ml of the critical value,were respectively 76. 00%,80. 00% and 76. 00%,the combined detection were98. 00%,94. 00% and 95. 00% respectively,combined detection were significantly higher than the 3 factors alone,the difference was statistically significant( P 〈 0. 05). Conclusion Serum levels of CA125,CEA and TAM are associated with gynecological malignant tumor,combined detection can effectively increase the efficiency of the diagnosis of benign and malignant lesions of gynecological tumors,it’s worthy of further clinical promotion.
作者 翟春霞 ZHAI Chunxia(The People's Hospital of Hebi,Hebi,45800)
出处 《实用癌症杂志》 2018年第6期1028-1030,共3页 The Practical Journal of Cancer
关键词 糖类抗原125 癌胚抗原 肽结合羟脯氨酸 妇科肿瘤 诊断 Carbohydrate antigen 125 Carcinoembryonic antigen Tumor related substances Gynecological tumors Diagnosis
  • 相关文献

参考文献7

二级参考文献64

  • 1Hui-ZhiWANG Hai-YanWANG Ru-QiangLIANG Kang-ChengRUAN.Detection of Tumor Marker CA125 in Ovarian Carcinoma Using Quantum Dots[J].Acta Biochimica et Biophysica Sinica,2004,36(10):681-686. 被引量:15
  • 2罗兴洪,刘武.恩度[J].中国新药杂志,2006,15(21):1893-1895. 被引量:10
  • 3Spahn M, Weiss C, Bader P, et al. The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survival[ J ]. Urol Int,2010, 85(1) :16 -22.
  • 4Abdel-Azeez H A, Labib H A, Sharaf S M, et al. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses[J]. Asian Pac J Cancer Prev,2010,11 ( 1 ) :111 - 6.
  • 5Li J, Dowdy S, Tipton T, et al. HEal as a biomarker for ovarian and endometrial cancer management [ J ]. Expert Rev Mol Diagn, 2009, 9(6) :555 -66.
  • 6Tamakoshi K, Kikkawa F, Shibata K, et al. Clinical value of CA125, CA19-9, CEA, CA72-4 and TPA in borderline ovarian tumor[J]. Gynecol Oncol,1996,62( 1 ) : 67 - 72.
  • 7Sebastianelli A, Renaud M C, Gregoire J, et al. Preoperative CA 125 tumour marker in endometrial cancer: correlation with advanced stage disease [ J ].J Obstet Gynaecol Can, 2010,32 ( 9 ) : 856 - 60.
  • 8Davelaar E M, van de Lande J, von Mensdorff-Pouilly S, et al. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer[ J ]. Tumour Biol,2008, 29(1) :9 -17.
  • 9Yeung S C, Habra M A, Thosani S N. Lung cancer-induced paraneoplastic syndromes [ J ]. Curt Opin Pulm Med, 2011,17 ( 4 ) : 260 -8.
  • 10Price M A, Butow P N, Costa D S, et al. Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their caregivers[ J]. Med J Aust ,2010,193 ( 5 ) : S52 - 7.

共引文献107

同被引文献57

引证文献7

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部